Comerica Securities,Inc. Biomarin Pharmaceutical Inc Transaction History

Comerica Securities,Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$80.93 - $108.63 $15,214 - $20,422	188 New	188 $19,000
Q1 2022 Apr 28, 2022	SELL	$74.28 - $92.69 $435,355 - $543,256	-5,861 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$71.72 - $91.47 $11,762 - $15,001	-164 Reduced 2.72%	5,861 $518,000
Q3 2021 Nov 10, 2021	BUY	$74.77 - $85.47 $32,524 - $37,179	435 Added 7.78%	6,025 $466,000
Q2 2021 Aug 11, 2021	BUY	$75.51 - $84.79 $2,038 - $2,289	27 Added 0.49%	5,590 $466,000
Q1 2021 May 12, 2021	SELL	$74.73 - $90.69 $26,454 - $32,104	-354 Reduced 5.98%	5,563 $420,000
Q4 2020 Feb 09, 2021	SELL	$72.61 - $90.2 $4,937 - $6,133	-68 Reduced 1.14%	5,917 $519,000
Q3 2020 Nov 04, 2020	BUY	$71.87 - $131.03 $13,295 - $24,240	185 Added 3.19%	5,985 $455,000
Q2 2020 Jul 17, 2020	SELL	$79.55 - $124.22 $13,603 - $21,241	-171 Reduced 2.86%	5,800 $715,000
Q1 2020 Apr 16, 2020	SELL	$71.37 - $96.85 $40,680 - $55,204	-570 Reduced 8.71%	5,971 $504,000
Q4 2019 Feb 11, 2020	BUY	$64.27 - $86.37 $14,267 - $19,174	222 Added 3.51%	6,541 $553,000
Q3 2019 Oct 15, 2019	BUY	$67.4 - $85.11 $210,422 - $265,713	3,122 Added 97.65%	6,319 $426,000
Q3 2019 Oct 15, 2019	SELL	$67.4 - $85.11 $105,818 - $133,622	-1,570 Reduced 32.93%	3,197 $272,000
Q2 2019 Aug 09, 2019	BUY	$80.35 - $93.9 $103,249 - $120,661	1,285 Added 36.9%	4,767 $408,000
Q1 2019 May 07, 2019	BUY	$84.2 - $98.62 $293,184 - $343,394	3,482 New	3,482 $309,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

Stay updated on Comerica Securities,Inc. with notifications on news.